Ophthalmology

Cataracts and Age-Related Eye Changes

~9 min read8 sections
⭐ High-yield🎯 Drill Ophthalmology
Contents (8)

Cataracts are a progressive clouding of the normally transparent crystalline lens that develops over time and represent the leading cause of blindness worldwide. Age-related cataracts account for the majority of cataract cases, with prevalence increasing dramatically after age 60, affecting >50% of adults by age 80. Beyond cataracts, aging eyes undergo characteristic changes including presbyopia, arcus senilis, and increased risk of age-related macular degeneration (AMD), glaucoma, and other conditions that collectively impact visual function. Understanding the pathophysiology, clinical presentation, and management of these conditions is essential for comprehensive geriatric ophthalmologic care.

Non-modifiable / intrinsic

  • Aging (dominant cause): cumulative oxidation and crystallin cross-linking; the single strongest predictor of nuclear sclerosis.
  • Genetic and syndromic: myotonic dystrophy (classically an iridescent "Christmas tree" cataract), Down syndrome, Wilson disease ("sunflower" cataract from copper deposition in the anterior capsule), neurofibromatosis type 2 (juvenile posterior subcapsular).
  • Congenital/metabolic in infancy: classic galactosemia and galactokinase deficiency — accumulated galactitol from aldose reductase draws water into the lens osmotically; also TORCH infection, especially congenital rubella.
  • Ocular disease: chronic uveitis, retinitis pigmentosa, high myopia, prior vitrectomy or intraocular surgery, pseudoexfoliation syndrome (also weakens zonules).

Modifiable / exposure-related

  • Cigarette smoking: oxidative injury plus heavy-metal (cadmium) accumulation; dose-dependent risk for nuclear cataract and reversible with cessation, which the AAO Preferred Practice Pattern for Cataract in the Adult Eye lists among the few evidence-supported preventive measures.
  • Ultraviolet-B exposure: photo-oxidation of crystallins; supports UV-blocking lenses.
  • Corticosteroids (any route — topical, inhaled, oral, intra-articular): the classic cause of posterior subcapsular cataract; migration and aberrant differentiation of lens epithelial cells posteriorly. Examiners plant chronic prednisone for asthma, transplant, or rheumatologic disease.
  • Diabetes mellitus: dual mechanism — sorbitol accumulation via aldose reductase (osmotic lens swelling, the acute "snowflake" cataract of poorly controlled young diabetics) and non-enzymatic glycation of crystallins. The ADA Standards of Care emphasize glycemic control and dilated eye examination in this population.
  • Trauma and radiation: blunt or penetrating injury (rosette-shaped cataract), electrical injury, and ionizing radiation; infrared exposure in glassblowers.
  • Other drugs: phenothiazines (chlorpromazine), amiodarone, and long-term miotics; tamsulosin does not cause cataract but complicates its surgery.
  • Systemic/nutritional: atopic dermatitis (shield cataract), chronic hypocalcemia/hypoparathyroidism, severe malnutrition and dehydrating illness.

Cataract Formation — Molecular and Cellular Mechanisms

  • Oxidative stress and protein damage: The lens lacks blood vessels and relies on antioxidant systems (superoxide dismutase, catalase, glutathione peroxidase) to protect lens proteins. Age-related decline in antioxidant capacity allows free radicals to damage lens crystallins (α, β, and γ proteins), causing cross-linking and protein aggregation that scatters light
  • Lens fiber cell loss and dehydration: Lens epithelial cells differentiate into lens fibers throughout life, but aging epithelium becomes dysfunctional. Loss of aquaporin-0 (water channel protein) and Na+/K+ ATPase pump function leads to osmotic imbalance, cell swelling, and fiber disorganization
  • Glycation and advanced glycation end products (AGEs): Chronic hyperglycemia (in diabetes) causes non-enzymatic glycosylation of lens proteins, accelerating protein cross-linking and cataract formation
  • Calcium and zinc accumulation: Impaired ion homeostasis in aging lenses leads to increased intracellular calcium, activating calpains (proteases) that degrade lens structural proteins
  • Lipid peroxidation and membrane dysfunction: Oxidation of lens membrane lipids reduces membrane fluidity and increases permeability, disrupting the ionic gradients necessary for lens transparency

Age-Related Changes in Other Ocular Structures

  • Presbyopia: Loss of lens elasticity due to increased lens protein cross-linking and weakening of ciliary muscle accommodation, resulting in decreased near vision after age 40
  • Arcus senilis: Lipid deposition in the peripheral cornea (Descemet membrane), creating a white-gray ring; benign but may indicate systemic dyslipidemia
  • Vitreous changes: Liquefaction and posterior vitreous detachment (PVD) with age, increasing risk of floaters and retinal tears
  • Retinal pigment epithelium (RPE) dysfunction: Accumulation of lipofuscin and drusen, predisposing to AMD

Subjective Symptoms

  • Gradual vision loss: Progressive, painless blurring and dimming of vision over months to years; bilateral but often asymmetric
  • Glare and haloes: Increased sensitivity to bright light and difficulty with night driving due to light scattering through the opaque lens
  • Monocular diplopia (polyopia): Multiple images from light refraction through cataract regions; distinguish from binocular diplopia suggesting extraocular muscle pathology
  • Refractive shift (myopic shift): Early cataracts increase lens refractive power, causing temporary myopic shift and ability to read without glasses ("second sight of aging")
  • Color desaturation: Colors appear muted or yellowish due to light absorption by cataract

Objective Clinical Findings

  • White or opaque appearance of pupil on examination: May be visible to naked eye in advanced ("mature") cataracts; best visualized with slit-lamp biomicroscopy
  • Reduced red reflex: Critical finding on ophthalmoscopy; opacity blocks the reflex from the retina; best assessed with dilated examination
  • Cataracts appear as specific morphologic types: Nuclear (hardening and browning of central nucleus), cortical (spoke-like opacities radiating from periphery), posterior subcapsular (small opaque dots under lens capsule causing disproportionate glare symptoms despite preserved acuity)
  • Decreased visual acuity with normal pupil responses: Distinguishes cataract from other causes of vision loss
  • Presbyopia findings: Inability to focus on near objects; correctable with reading glasses

Clinical Examination Approach

  • Distance and near visual acuity assessment: Measure with and without pinhole (pinhole improves vision with refractive error but NOT with cataract); reduced acuity despite pinhole suggests dense cataract
  • Slit-lamp biomicroscopy (gold standard): Direct visualization of lens opacities; allows categorization by location (nuclear, cortical, subcapsular) and quantification of density
  • Red reflex assessment: Loss of red reflex indicates cataract of sufficient density to affect vision; compare both eyes
  • Dilated fundoscopy: Rule out posterior segment pathology (AMD, diabetic retinopathy, optic neuropathy) that may contribute to vision loss or affect surgical candidacy
  • Refraction assessment: Note any refractive shift suggestive of early nuclear cataract

Specialized Testing

  • Contrast sensitivity testing: More sensitive than standard acuity in detecting functional impact; useful when acuity appears preserved but patient reports significant visual dysfunction
  • Optical coherence tomography (OCT) and optical biometry: Obtained preoperatively to assess macula and calculate intraocular lens (IOL) power
  • Imaging studies are generally NOT needed: Cataracts are clinical diagnosis; neuroimaging not indicated unless vision loss is unexplained or nonprogressive

Diagnostic Criteria

  • Cataracts are graded on Lens Opacity Classification System (LOCS) from grade 0 (clear) to grade 4 (complete opacity)
  • "Visually significant cataract" = cataract explaining patient's symptoms AND acuity ≤20/40 (though surgery may be considered with better acuity if functional impairment is significant)

Conservative Management (Early/Mild Cataracts)

  • Observation and reassurance: Most cataracts progress slowly; no medications prevent progression
  • Refractive correction update: Trial of new glasses prescription may improve vision temporarily
  • Bright lighting and magnification: Behavioral modifications for functional support
  • UV protection and antioxidant diet: Wearing UV-protective sunglasses and consuming vitamins C and E may slow progression, though evidence is modest
  • Address comorbidities: Optimize glycemic control in diabetes and manage hypertension to reduce cataract progression

Surgical Intervention (Definitive Treatment)

  • Phacoemulsification (standard approach): Small incision, ultrasound fragmentation of nucleus, removal of cortex and nucleus, leaving capsular bag intact for IOL placement. Success rate >95%; performed as outpatient with topical anesthesia
  • Extracapsular cataract extraction (ECCE): Larger incision; reserved for very dense "mature" cataracts or poor surgical candidates; higher astigmatism than phacoemulsification
  • Femtosecond laser-assisted cataract surgery (FLACS): Emerging technology; allows automated capsulotomy and lens fragmentation but adds cost without clearly proven superiority
  • Intraocular lens (IOL) placement: Implanted in capsular bag after cataract removal; corrects aphakia and reduces need for thick glasses; multiple IOL options (standard monofocal, multifocal, toric for astigmatism, extended depth of focus)

Indications for Surgery

  • Visually significant cataract (acuity ≤20/40 or contrast sensitivity impairment) causing functional limitation
  • Earlier surgery may be considered if impact on activities (driving, occupational demands) is significant despite preserved acuity
  • Medical indications: Dense cataract preventing fundus examination in patient with suspected retinal pathology; cataract contributing to angle-closure glaucoma risk
  • Patient-centered timing: Patient readiness and desire for improvement paramount; no urgent indication unless vision threat

Perioperative Management

  • Preoperative workup: Biometry for IOL calculation, topography for astigmatism assessment, anterior segment OCT if dense media
  • Medications: Continue all systemic medications; topical antibiotics and anti-inflammatories (NSAIDs + corticosteroids) given perioperatively

Complications of untreated cataract

  • Phacomorphic angle-closure glaucoma (emergency): an intumescent, swollen lens pushes the iris forward and closes the angle — acute pain, halos, mid-dilated non-reactive pupil, corneal edema, rock-hard eye with markedly elevated IOP. Requires immediate IOP lowering and urgent lens extraction.
  • Phacolytic glaucoma (emergency): a hypermature/*Morgagnian* cataract leaks liquefied crystallins through an intact capsule; macrophages engorged with lens protein obstruct the trabecular meshwork. Look for a white lens, heavy anterior chamber cell/flare, and high IOP.
  • Lens-induced (phacoantigenic) uveitis: exposure of sequestered lens protein after capsular breach provokes granulomatous inflammation.
  • Deprivation amblyopia (time-critical in infants): a visually significant congenital cataract must be removed within the first weeks to months of life or the visual cortex never develops normally.
  • Falls, hip fracture, and driving injury: the reason the AAO frames surgery around functional impairment rather than a Snellen number alone.

Complications of cataract surgery

  • Acute postoperative endophthalmitis (emergency): days after surgery — pain, sudden vision loss, lid edema, and hypopyon. Same-day vitreous tap with intravitreal antibiotics (vancomycin plus ceftazidime); the Endophthalmitis Vitrectomy Study supported immediate pars plana vitrectomy when vision is light-perception only.
  • Posterior capsular opacification (most common late complication): residual lens epithelial cells proliferate on the capsule (Elschnig pearls), causing gradual glare and blur months to years later. Treated with Nd:YAG laser capsulotomy, not repeat surgery.
  • **Cystoid macular edema (Irvine–Gass syndrome)**: prostaglandin-mediated perifoveal leakage weeks postoperatively; OCT shows cystic spaces, angiography a petaloid pattern. Topical NSAID plus steroid.
  • Posterior capsule rupture with vitreous loss or dropped nucleus; IOL dislocation (pseudoexfoliation, zonular weakness) with a *phacodonesis*/edge-of-lens visual complaint.
  • Intraoperative floppy iris syndrome: alpha-1a antagonists such as tamsulosin — always ask about it preoperatively.
  • Corneal endothelial cell loss → pseudophakic bullous keratopathy, retinal detachment (higher with axial myopia and after YAG), and rare suprachoroidal hemorrhage.

  • Steroids = posterior subcapsular: a patient on chronic prednisone (transplant, asthma, lupus) with glare while night driving and near-vision complaints out of proportion to Snellen acuity. Posterior subcapsular cataracts sit at the nodal point of the eye, so they hurt most when the pupil constricts — in bright light and at near.
  • Absent red reflex in a newborn is never observed — it is leukocoria until proven otherwise. The single best next step is urgent pediatric ophthalmology referral to distinguish congenital cataract from retinoblastoma; AAP/AAO recommend red reflex testing at every well-child visit.
  • The metabolic association examiners love: an infant with cataracts, hepatomegaly, and E. coli sepsis after starting milk = classic galactosemia; isolated cataracts alone = galactokinase deficiency. Mechanism is galactitol, generated by aldose reductase.
  • "Second sight": an elderly patient who suddenly no longer needs reading glasses has a myopic shift from nuclear sclerosis, not improving eyes.
  • Monocular diplopia persists when the other eye is covered and localizes to the media (cataract, corneal irregularity). Binocular diplopia that resolves on covering either eye is neuromuscular — think cranial nerve palsy or myasthenia; do not order a CT head for monocular diplopia.
  • Pinhole test is the cheapest discriminator: it improves refractive error but not cataract or retinal/optic nerve disease.
  • Post-op timing rules the answer: pain plus hypopyon within days = endophthalmitis (emergency tap-and-inject); painless gradual blur months to years later = posterior capsular opacification (Nd:YAG capsulotomy).
  • Common distractor: no drop, vitamin, or diet reverses a cataract — surgery is the only definitive therapy, and the AAO bases the indication on functional impairment, not on a threshold acuity number alone.
  • Ask about tamsulosin before surgery (floppy iris syndrome), and never attribute unexplained persistent vision loss after successful surgery to the lens — check the macula for AMD or cystoid macular edema.

Related topics

← Back to library